Archive for Osteoarthritis
10th World Conference on Osteoarthritis December 8th ? 11th; Promising Research for Osteoarthrits Sufferers Being Presented
10th World Conference on Osteoarthritis December 8th – 11th Promising Research for Osteoarthrits Sufferers Becoming Presented
Boston, MA (PRWEB) December 8, 2005
A poster presentation taking location on Friday looks at the differential effects of chondroitin sulfate on osteoarthritis symptoms related to degree of radiographic involvement. When treating osteoarthritis, doctors look to treat two distinct targets—pain and the progression of the disease. Whilst the overall results of the NIH GAIT study have focused purely on discomfort measured on the WOMAC scale, several other results with various measurement scales are emerging. This newest data is significant because it is employing the Kellgren and Lawrence scale, which is another way to evaluate the joint and the phase of the disease in an osteoarthritis patient, by searching into the radiographic evaluation of a joint.
The patients that had been evaluated had been in two certain groups on the K&L scale: Groups 2 and 3, where the measurement of space between the joints was minimal (2), or moderate (three). Essentially the results showed that patients in Group 2 showed considerable improvement with chondroitin sulfate vs. placebo in stiffness, function and joint swelling and in Group 3, joint swelling was decreased.
Doctors treating patients are constantly concerned about how to stop or reverse the progression of osteoarthritis. Getting the discomfort under control is the very first step, but then dealing with all the other symptoms such as joint swelling, stiffness and function are as important. It is a vicious cycle, joint swelling in 90% of patients is caused by joint effusion. Joint effusion is an enhance of liquid inside the articular space—it produces discomfort and functional incapacity. Says Nicholas DiNubile, MD an orthapeodic surgeon “ It’s crucial when treating osteoarthritis to break that cycle and treat the illness. I discover that joint supplements are a extremely efficient and risk-totally free way of doing that and it’s good to have information that supports what I see in my clinical practice everyday.” Dr. DiNubile has over 25 years encounter in treating osteoarthritis. Chosen as one of the “Best Doctors in America”, DiNubile has been the recipient of the prestigious Healthy American Fitness Leaders award and also served as special advisor and medical consultant to The President’s Council on Physical Fitness and Sports under the first Bush Administration.
The data contained in this release was extracted from the poster becoming presented at the conference by Dr.Clegg, lead researcher on the GAIT study. Dr. Clegg concluded that the outcomes suggest chondroitin sulfate may well improve osteoarthritis knee discomfort in patients with relatively early radiographic disease.
Bioiberica is the leading manufacturer of pharmaceutical-grade chondroitin sulfate and was selected by the NIH as the exclusive supplier of chondroitin sulfate for the GAIT study.
For more details, or to arrange an interview with a company spokesperson or a member of the medical advisory panel, please contact Leesa Raab at ADinfinitum, 212-693-2150 Ext. 309.
# # #
©Copyright 1997-
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
HealthMark Multimedia Launches Web Site for Persons With Osteoarthritis
(PRWEB) May possibly 28, 2004
HealthMark Multimedia has launched internet site for adults with osteoarthritis, MyArthritisManager.com. This web internet site uniquely adapts the well-tested Stages of Change model for behavior change to help those with osteoarthritis incorporate self-management into their daily lives.
The site, www.myarthritismanager.com, was developed with funding from the National Institute of Arthritis & Musculoskeletal & Skin Diseases. The internet web site has interactive tools and graphics, text and audio info about self-management of osteoarthritis. Self-management approaches in the areas of diet and nutrition, tension management, physical activity are covered by the web site. The web site is presently being evaluated nationally to establish if use helps persons make changes and learn to self-manage their osteoarthritis.
About HealthMark Multimedia
A certified woman-owned small business, HealthMark Multimedia’s goal is to offer comprehensive, balanced health data that is medically accurate, yet effortless to comprehend and apply to making informed health decisions. These products are special in combining rich audio-visual and interactive elements. The benefit of this special mixture is a a lot more personalized resource, with a human face, that is reassuring to patients and aids in assimilation. The company’s special and dynamic item development method includes input from medical specialists and end-users, such as patients and their family members and friends, to make sure that info is accurate, relevant and useful. This is accomplished by way of medical professional reviews, usability testing, focus groups and effectiveness testing.
# # #
Which of your Fibromyalgia symptoms bothers you the most?
Question by tonyer71: Which of your Fibromyalgia symptoms bothers you the most?
I have Fibro, “advanced form of Osteoarthritis” (whatever that means), migraines, and psoriasis. I had to have a spinal fusion last summer. I’m accustomed to pain, but the complete and total exhaustion….I just can’t stand it!!!! Seems I can’t get anything done anymore. Even a shower and I feel like I need a nap.
What is your biggest complaint?
Best answer:
Answer by DavidJohn
Please be aware that many members of the health care community consider fibromyalgia to be a bogus diagnosis. This term means literally “sore tissue”, not really a diagnosis. If you are not being seen by a pain specialist, seek one out. Most Docs use fibromyalgia to mean “i don’t know what is wrong”. I encourage you to seek better answers. There is NO test that a doc can do to diagnose fibromyalgia, therefore its benefit as a diagnosis is questionable.
Good luck in your quest for comfort.
Add your own answer in the comments!
Osteoarthritis – Drug Pipeline Analysis And Market Forecasts To 2016
GlobalData, the industry analysis specialist’s new report, “Osteoarthritis – Drug Pipeline Analysis and Market Forecasts to 2016″ is an essential source of information and analysis on the global osteoarthritis market. The report identifies the key trends shaping and driving the global osteoarthritis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global osteoarthritis sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.
Scope
The report analyzes market opportunities and challenges for the global osteoarthritis market. Its scope includes
– Annualized global osteoarthritis market revenues data from 2001 to 2009, forecast forward for 7 years to 2016.
– Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France and Japan.
– Pipeline analysis data providing a split across different phases by mechanism of action being developed and emerging trends. Key classes of mechanism of action include serotonin-norepinephrine reuptake inhibitors, calcium homeostasis regulators, and proton pump inhibitors, inhibitor of 5-lipoxygenase and cyclooxygenase, opioid receptor agonist, stem cell therapy, cartilage cell synthesizer.
– Analysis of the current and future market competition in the global osteoarthritis market. Key market players covered are Novartis AG, Pfizer, Inc., Johnson & Johnson and Abbott Laboratories
– Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
– Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with osteoarthritis market.
Reasons to buy:
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
– Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
– Develop business strategies by understanding the trends shaping and driving the global osteoarthritis market.
– Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global osteoarthritis market in future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
– What’s the next big thing in the global osteoarthritis market landscape? – Identify, understand and capitalize.
Table of contents
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Osteoarthritis Market: Market Characterization 5
2.1 Overview 5
2.2 Osteoarthritis Therapeutics Market Size 5
2.3 Osteoarthritis Market Forecast and CAGR 6
2.4 Drivers and Barriers for the Osteoarthritis Therapeutics Market 7
2.4.1 Drivers for the Osteoarthritis Therapeutics Market 7
2.4.2 Barriers for the Osteoarthritis Therapeutics Market 8
2.5 Opportunity and Unmet Need 8
2.6 Key Takeaway 9
3 Osteoarthirtis Market: Competitive Assessment 10
3.1 Overview 10
3.2 Strategic Competitor Assessment 10
3.3 Product Profiles of the Major Marketed Products in the Osteoarthritis Therapeutics Market 11
3.3.1 Voltaren Gel 11
3.3.2 Celebrex 11
3.3.3 Hyalgan 12
3.3.4 Mobic 12
3.4 Key Takeaway 13
4 Osteoarthritis Market: Pipeline Assessment 14
4.1 Overview 14
4.2 Strategic Pipeline Assessment 14
4.2.1 Technology Trends Analytic Framework 14
4.3 Osteoarthritis Therapeutics – Promising Drugs under Clinical Development 15
4.4 Molecule Profile for Promising Drugs under Clinical Development 16
4.4.1 SD6010 16
4.4.2 PF-4383119 16
4.4.3 TDS-943 16
4.4.4 SMC021 17
4.4.5 CG5503 17
4.4.6 Vicodin CR 18
4.5 Osteoarthritis Market – Clinical Pipeline by Mechanism of Action 18
4.6 Osteoarthritis Pipeline – Pipeline by Clinical Phases of Development 19
4.6.1 Osteoarthritis Therapeutics – Phase III Clinical Pipeline 20
4.6.2 Osteoarthritis Therapeutics – Phase II Clinical Pipeline 23
4.6.3 Osteoarthritis Therapeutics – Phase I Clinical Pipeline 25
4.6.4 Osteoarthritis Therapeutics – Discovery Pipeline 26
4.6.5 Osteoarthritis Therapeutics – Discontinued Pipeline 26
4.7 Key Takeaway 26
5 Osteoarthritis Market: Implications for Future Market Competition 27
6 Osteoarthritis Market: Future Players in the Osteoarthritis Market 28
6.1 Introduction 28
6.2 Novartis Pharma AG 28
6.2.1 Overview 28
6.2.2 Osteoarthritis Disease Portfolio 29
6.2.3 SMC021 29
6.3 Pfizer Inc. 29
6.3.1 Overview 29
6.3.2 Osteoarthritis Disease Portfolio 30
6.3.3 SD6010 30
6.3.4 PF-4383119 30
6.3.5 TDS-943 31
6.4 Johnson and Johnson 31
6.4.1 Company Overview 31
6.4.2 Osteoarthritis Disease Portfolio 32
6.4.3 CG5503 32
6.5 Abbott Laboratories 32
6.5.1 Company Overview 32
6.5.2 Osteoarthritis Disease Portfolio 33
6.5.3 Vicodin CR 33
7 Osteoarthritis Market: Appendix 34
7.1 Definitions 34
7.2 Acronyms 34
7.3 Research Methodology 34
7.3.1 Coverage 35
7.3.2 Secondary Research 35
7.3.3 Forecasting 36
7.3.4 Primary Research 38
7.3.5 Expert Panel Validation 39
7.4 Contact Us 39
7.5 Disclaimer 39
7.6 Sources 39
ReportsandReports comprising of an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. ReportsandReports announce to have Osteoarthritis – Drug Pipeline Analysis and Market Forecasts to 2016 Market Research Report in its store. Browse all our Market Research Reports details at ReportsandReports.com
Article from articlesbase.com
Related Osteoarthritis Articles